Chronix Biomedical

About:

Chronix Biomedical is a molecular diagnostics company developing blood tests for monitoring minimal residual disease in cancer patients.

Website: http://www.chronixbiomedical.com

Twitter/X: chronixbio

Top Investors: Pentagram, VA Angels, PrairieGold Venture Partners, Boston Harbor Angels

Description:

Chronix Biomedical is pioneering a breakthrough approach to the diagnosis and management of chronic diseases and cancer. It has developed proprietary technology that measures and categorizes circulating nucleic acids, DNA sequences circulating in the blood that are associated with specific changes in disease and health status. Chronix plans to collaborate with a variety of partners to develop and market its DNA-based assays that have the potential to transform the management of a broad range of cancers and other conditions. Chronix is headquartered in San Jose, California and has research facilities in Germany.